Leiden University Medical Center
It has recently become clear that many aspects of the immune system are under circadian control, but little is still known about the interplay between circadian rhythms and antitumor immunity. My PhD project at the Department of Immunology at LUMC aims to investigate the role of the circadian clock in the response to cancer immunotherapies. I am specifically interested in the function of T cells, which are key components of antitumor immunity, within this context.
The BioClock Consortium is funded by the NWA-ORC programme of the Dutch Research Council (NWO; project number 1292.19.077).